Detalhe da pesquisa
1.
Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screen.
Mol Oncol
; 15(8): 2026-2045, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33759347
2.
Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition.
Cell Rep
; 35(13): 109291, 2021 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34192548
3.
Proteoglycans as Mediators of Cancer Tissue Mechanics.
Front Cell Dev Biol
; 8: 569377, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33330449
4.
Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells.
Sci Rep
; 10(1): 16992, 2020 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33046784
5.
O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes.
Sci Rep
; 9(1): 5670, 2019 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30952976
6.
Metabolic re-wiring of isogenic breast epithelial cell lines following epithelial to mesenchymal transition.
Cancer Lett
; 396: 117-129, 2017 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28323032
7.
Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors.
Oncotarget
; 7(15): 19997-20015, 2016 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26918352
8.
Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism.
Oncotarget
; 7(11): 12464-76, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26824323
9.
Metabolic reprogramming supports the invasive phenotype in malignant melanoma.
Cancer Lett
; 366(1): 71-83, 2015 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26095603